Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart

Environmental Toxicology and Pharmacology

Volumn 31, Issue 1, 2011, Pages 33-41

  Messarah, Mahfoud ^a   Saoudi, Mongi ^b   Boumendjel, Amel ^a   Boulakoud, Mohamed Salah ^a   Feki, Abdelfattah El ^b  

^a BADJI MOKHTAR UNIVERSITY   (Algeria)

^b UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Biochemical parameters; Erythrocytes; Heart; Lipid peroxide; Oxidative stress; Rat; Thyroid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BENZYLTHIOURACIL; CATALASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; LACTATE DEHYDROGENASE; LEVOTHYROXINE SODIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; ERYTHROCYTE COUNT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GROWTH RATE; HEART DISEASE; HEART WEIGHT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HYPERTHYROIDISM; HYPOTHYROIDISM; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER INJURY; LONG TERM EXPOSURE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; THYROID WEIGHT; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; BLOOD CELL COUNT; BODY WEIGHT; DRINKING; EATING; ERYTHROCYTES; GLUTATHIONE; HEART; HEART FUNCTION TESTS; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID PEROXIDATION; LIVER FUNCTION TESTS; MALE; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THYROXINE; TRIIODOTHYRONINE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78650212143     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.09.003     Document Type: Article

References (49)

1. Aebi H. Catalase. Methods of Enzymatic Analysis 1974, vol. 2:673-884. Academic Press, New York.
2. Araujo A.S.R., Ribeiro M.F.M., Enzveiler A., Schenkel P., Fernandes T.R.G., Partata W.A., Irigoyen M.C., Llesuy S., Belló-Klein A. Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism. Mol. Cell. Endocrinol. 2006, 249:133-139.
3. Asada K., Takahashi M., Nagate M. Assay and inhibitors of spinach superoxide dismutase. Agric. Biol. Chem. 1974, 38:471-473.
4. Bradford M. A rapid and sensitive method for the quantities of microgram quantities of protein utilizing the principle of protein binding. Anal. Biochem. 1976, 72:248-254.
5. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1984, 105:302-310.
6. Cappola A.R., Fried L.P., Arnold A.M., Danese M.D., Kuller L.H., Burke G.L., Tracy R.P., Ladenson P.W. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006, 295:1033-1041.
7. Castitho R.F., Kowaltowski A.J., Vercesi A.E. 3,5,3-triodothyronine induces mitochondrial permeability transition mediated by reactive oxygen species and membrane protein thiol oxidation. Arch. Biochem. Biophys. 1998, 345:151-157.
8. Cini G., Carpi A., Mechanick J., Cini L., Camici M., Galetta F., Giardino R., Russo M.A., Iervasi G. Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed. Pharmacother. 2009, 63:742-753.
9. Clemens R., Waller H.D. Lipid peroxidation in erythrocytes. Chem. Phys. Lipids 1987, 45:251-268.
10. Danzi S., Ojamaa K., Klein I. Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:2255-2262.
11. Das K., Chainy G.B.N. Modulation of liver mitochondrial antioxidant defense system by thyroid hormone. Biochem. Biophys. Acta 2001, 1573:1-13.
12. Dillmann W. Biochemical basis of thyroid action in the heart. Am. J. Med. 1990, 88:626-630.
13. Dodge J.T., Mitchell C., Hananan D.J. The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes. Arch. Biochem. Biophys. 1963, 100:119-130.
14. Duntas L.H., Biondi B. Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur. J. Endocrinol. 2007, 156:13-19.
15. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem. Biophys. 1959, 82:70-77.
16. Fadel B.M., Ellahham S., Ringel M.D., Lindsay J., Wartofsky L., Burman K.D. Hyperthyroid heart disease. Clin. Cardiol. 2000, 23:402-408.
17. Faure M., Lissi E.A., Videla L.A. Evaluation of the antioxidant properties of thyroid hormones and propyl thiouracil in the brain homogenate autooxidation system and in the free radical mediated oxidation of erythrocytes membranes. Chem. Biol. Interact. 1991, 77:173-185.
18. Fernandez V., Tapia G., Varela P., Cornejo P., Videla L.A. Upregulation of liver inducible nitric oxide synthase following thyroid hormone preconditioning: suppression by N-acetylcysteine. Biol. Res. 2009, 42:487-495.
19. Ferreira E., Silva A.E., Serakides R., Gomes A.E.S., Cassali G.D. Model of induction of thyroid dysfunctions in adult female mice. Arq. Bras. Med. Vet. Zootec. 2007, 59:1245-1249.
20. Flohe L., Gunzler W.A. Analysis of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
21. Ghose Roy S., Mishra S., Ghosh G., Bandyopadhyay A. Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1. Matrix Biol. 2007, 26:269-279.
22. Göktekin E., Barlas N. Histopathological effects of 4-tert-octylphenol treatment through the pregnancy period, on the pituitary, adrenal, pancreas, thyroid and parathyroid glands of offspring rats at adulthood. Environ. Toxicol. Pharmacol. 2008, 26:199-205.
23. Guerrero A., Pamplona R., Portero-Otin M., Barja G., Lopez-Torres M. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Radic. Biol. Med. 1999, 26:73-80.
24. Ježek P., Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell. Biol. 2005, 37:2478-2503.
25. Jollow D.J., Mitchell J.R., Zamppaglione Z., Gillette J.R. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolites. Pharmacology 1974, 11:51-157.
26. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344:501-509.
27. López-Torres M., Maria R., Barja G. Effect of hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart. Mol. Cell. Endocrinol. 2000, 168:127-134.
28. Majima T., Komatsu Y., Doi K., Takagi C., Shigemoto M., Fukao A., Morimoto T., Corners J., Nakao K. Clinical significance of risedronate for osteoporesis in the initial treatment of male patients with Graves' disease. J. Bone Miner. Metab. 2006, 24:105-113.
29. Messarah M., Boumendjel A., Chouabia A., Klibet F., Abdennour C., Boulakoud M.S., El Feki A. Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Exp. Toxicol. Pathol. 2010, 62:301-310.
30. Messarah M., Boulakoud M.S., Boumendjel A., Abdennour C., El Feki A. The impact of thyroid activity variations on some oxidizing-stress parameters in rats. C. R. Biol. 2007, 330:107-112.
31. Morkin E., Pennock G.D., Spooner P.H., Bahl J.J., Goldman S. Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 2002, 12:527-533.
32. Pamplona R., Portero-Otin M., Ruiz C., Bellmunt M.J., Requena J.R., Thrope J.W., Romero M., Lopez-Torres J.R., Barja G. Thyroid status modulates glycooxidative and lipooxidative modification of tissue proteins. Free Radic. Biol. Med. 1999, 27:901-910.
33. Pantos C., Mourouzis I., Xinaris C., Kokkinos A.D., Markakis K., Dimopoulos A., Panagiotou M., Saranteas T., Kostopanagiotou G., Cokkinos D.V. Time-dependent changes in the expression of thyroid hormone receptor alpha1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling. Eur. J. Endocrinol. 2007, 156:415-424.
34. Pingitore A., Iervasi G., Barison A., Prontera C., Pratali L., Emdin M., Giannessi D., Neglia D. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J. Card. Fail. 2006, 12:520-526.
35. Polikar R., Burger A.G., Scherrer U., Nicod P. The thyroid and the heart. Circulation 1993, 87:1435-1441.
36. Rajadurai M., Stanely M.P.P. Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol induced myocardial infarction in Wistar rats. Toxicology 2007, 230:178-188.
37. Rodondi N., Bauer D.C., Cappola A.R., Cornuz J., Robbins J., Fried L.P., Ladenson P.W., Vittinghoff E., Gottdiener J.S., Newman A.B. Subclinical thyroid dysfunction. Cardiac function, and the risk of heart failure. J. Am. Coll. Cardiol. 2008, 52:152-159.
38. Roffi M., Cattaneo F., Brandle M. Thyrotoxicosis and the cardiovascular system. Miner. Endocrinol. 2005, 30:47-58.
39. Schmidt-Ott U.M., Ascheim D.D. Thyroid hormone and heart failure. Curr. Heart Fail. 2006, 3:114-119.
40. Schriks M., Roessig J.M., Murk A.J., Furlow J.D. Thyroid hormone receptor isoform selectivity of thyroid hormone disrupting compounds quantified with an in vitro reporter gene assay. Environ. Toxicol. Pharmacol. 2007, 23:302-307.
41. Scruggs S.B., Walker L.A., Lyu T., Geenen D.L., Solaro R.J., Buttrick P.M., Goldspink P.H. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation. J. Mol. Cell. Cardiol. 2006, 40:465-473.
42. Şener G., Şehirli Ö., Velioǧlu-Öǧünç A., Ercan F., Erkanli{dotless} G., Gedik N., Yeǧen B.Ç. Propylthiouracil (PTU)-induced hypothyroidism alleviates burn-induced multiple organ injury. Burns 2006, 32:728-736.
43. Shinohara R., Mano T., Nayashi R., Uchimura K., Nakano I., Watanabe F., Tsugawa T., Makino H., Kakizawa N., Nagata K., Iwase Y., Ishizuki M.I. Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status. J. Endocrinol. 2000, 164:97-102.
44. Silvestri E., Schiavo L., Lombardi A., Goglia F. Thyroid hormones as molecular determinants of thermogenesis. Acta Physiol. Scand. 2005, 184:265-283.
45. Taleux N., Guigas B., Dubouchaud H., Moreno M., Weitzel J.M., Goglia F., Favier R., Leverve X.M. High expression of thyroid hormone receptors and mitochondrial glycerol-3-phosphate dehydrogenase in the liver is linked to enhanced fatty acid oxidation in Lou/C, a rat strain resistant to obesity. J. Biol. Chem. 2008, 284:4308-4316.
46. Venditti P., Di Meo S. Thyroid hormone-induced oxidative stress. Cell. Mol. Life Sci. 2006, 63:414-434.
47. 2 production and susceptibility to oxidative stress of rat liver mitochondria. Arch. Biochem. Biophys. 2006, 447:11-22.
48. Wu Y., Koenig R.J. Gene regulation by thyroid hormone. Trends Endocrinol. Metab. 2000, 11:207-211.
49. Yogeeta S.K., Gnanapragasam A., Kumar S.S., Subhashini R., Sathivel A., Devaki T. Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 2006, 283:139-146.